Research Article
Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment
Figure 1
Eyes with subretinal fluid (SRF) before and after spironolactone treatment. After spironolactone treatment, 14 eyes (82.4%) showed complete resolution of the SRF (). However, among 14 eyes with complete resolution of SRF, SRF reappeared after discontinuation of spironolactone treatment in 9 eyes (64.3%, ).